MedBio Business Accelerator
Virtual Event | Friday, April 17 | 8 AM – 2 PM PT
The GLP-1 & Peptide Summit | MedBio Business Accelerator is a 6-hour, business-focused session for clinic owners who want stronger pricing, better patient acquisition and retention, compliant peptide integration, and scalable systems.
Ticket price
$199 Tier 2 tickets $119 instead
Reserve your seat at the promo price.
Bringing your whole team? Fill out the form below and we'll reach out with a custom quote.
Groups of 3 or more receive an additional 5% off.
This summit is designed for clinic owners and medical providers who:

GLP-1s alone are no longer a strategy.
Growth now requires:
Structured program design
Strategic peptide integration
Stronger retention systems
Smarter patient acquisition
Trusted partner alignment
Exact sessions and full speaker lineup are being finalized. The full agenda will be published by Wednesday, March 18th.

At the start of the Summit, you'll receive the MedBio Business Accelerator Playbook — a structured planning guide designed to help you organize and strengthen your GLP-1 and peptide revenue strategy.
Inside, you'll find guided frameworks to help you:

Ticket price – $199 Tier 2 tickets $119 instead




Clinic owners didn't just attend — they implemented structured pricing models, strengthened retention systems, and refined operations immediately after the event. Many reported increased lifetime patient value within months.
Demand was strong last year, and we expect the same again.
Reserve your seat at the promo price.
Ticket price: $199 Tier 2 tickets $119 instead
Is this event virtual?
Yes. It is hosted live online on April 17 from 8 AM – 2 PM PT.
Will there be a replay?
Yes. Replay access is included.
Is the Playbook included?
Yes. The full MedBio Business Accelerator Playbook is included with your ticket.
Will compliance be covered?
Yes. Responsible peptide integration and compliance are included in the agenda.
Can my team attend?
Each attendee requires their own ticket.
Refund policy?
All ticket sales are final.